EUGENE, Ore.--(BUSINESS WIRE)--Ksana Health, a digital behavioral health company that uses technology to provide continuous objective measurement, personalized insights and interventions to improve mental health care, today announced its selection by Novo Nordisk’s Global Prevention Accelerator. Organizations were selected based on a set of criteria including the ability to make a global impact and provide scalable digital solutions that can be adapted for local populations.
Earlier this year Novo Nordisk’s Global Prevention Accelerator invited startups developing digital solutions to submit proposals outlining how they can enable individuals and communities to predict and/or prevent obesity. The Prevention Accelerator will support selected organizations with funding to pilot their solutions with Novo Nordisk.
“Being selected by Novo Nordisk to be a part of the Prevention Accelerator program underscores the value of continuous objective measurement in addressing an urgent unmet need in behavioral health assessment and its critical role supporting overall improved health outcomes,” said Dr. Nick Allen, Co-Founder and CEO of Ksana Health. “Based upon a truly objective understanding of mental health's correlation with physical health diseases like obesity, we aim to give individuals and their healthcare providers personalized insights to improve overall health and wellbeing.”
“Novo Nordisk is embarking on new territory with great excitement in collaboration with Ksana Health. Ksana Health has a really interesting approach and we look forward to gaining learnings from the pilot. Furthermore, I am excited to see what this collaboration will bring for the future,” said Katrine DiBona, head of Global Public Affairs and Sustainability, Novo Nordisk A/S.”
Ksana Health will pilot its remote measurement platform, Vira, for health systems and care providers as part of the Prevention Accelerator. Vira delivers continuous objective measurement through a digitally enhanced platform that collects and converts measurable behavioral patterns into actionable, objective insights for individuals and their practitioners. In addition, Vira can help guide the development of a personalized plan supporting positive behavior change through timely, data-driven communication.
To learn more about Ksana Health’s selection by Novo Nordisk’s Global Prevention Accelerator, watch an interview with Dr. Nick Allen of Ksana Health.
ABOUT KSANA HEALTH
Ksana Health was founded in 2019 in Eugene, Oregon, to translate the tools and findings developed by the University of Oregon's Center for Digital Mental Health into products and services that transform mental health care and research. Led by Dr. Nick Allen, a Professor of Clinical Psychology with extensive research and clinical experience, and Will Shortt, an experienced software business leader and startup CEO, Ksana Health aims to give clients, practitioners, administrators, and researchers digital tools that are defining the future of mental health.
About Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders. We do so by pioneering scientific breakthroughs, expanding access to our medicines and working to prevent and ultimately cure disease. novonordisk.com